Six major compounds from sea grape (C. racemosa) extract were evaluated using an in silico approach against human pancreatic lipase, a-glucosidase, and a-amylase to predict prospective anti-obesity candidates. This evidence concerns the gene PNLIP and obesity due to melanocortin 4 receptor deficiency.